- Report
- March 2020
- 70 Pages
South Africa
From €4174EUR$4,750USD£3,600GBP
- Report
- July 2024
- 100 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- July 2024
- 150 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- July 2024
- 150 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- July 2024
- 150 Pages
Asia Pacific
From €3295EUR$3,750USD£2,842GBP
- Report
- July 2024
- 100 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- July 2024
- 100 Pages
Global
From €3295EUR$3,750USD£2,842GBP
- Report
- June 2024
- 200 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- June 2024
- 200 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- June 2024
- 200 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- June 2024
- 200 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- June 2024
- 200 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- March 2024
- 303 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- February 2024
- 119 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- February 2024
- 244 Pages
Global
From €6985EUR$7,950USD£6,026GBP
- Report
- November 2023
- 113 Pages
Global
From €6590EUR$7,500USD£5,685GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €1977EUR$2,250USD£1,705GBP
- Report
- June 2022
- 320 Pages
Global
From €12213EUR$13,900USD£10,535GBP
- Report
- March 2021
- 149 Pages
Global
From €6107EUR$6,950USD£5,268GBP
- Report
- July 2024
- 97 Pages
Middle East, Africa
From €3031EUR$3,450USD£2,615GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more